Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Positron Emission Tomography-Computed Tomography
97%
Fluorodeoxyglucose F 18
56%
Fluorine-18
39%
Fluorodeoxyglucose
32%
Bone Scintigraphy
31%
Technetium-99
31%
Single-Photon Emission Computed Tomography
27%
Polyethylene Terephthalate
25%
Sentinel Node
25%
Diseases
25%
Cancer
22%
Gamma Camera
21%
Neoplasm
21%
Single Photon Emission Computed Tomography-Computed Tomography
18%
Positron Emission Tomography
18%
Colorectal Carcinoma
17%
Lymphoscintigraphy
17%
Standardized Uptake Value
15%
Breast Imaging
14%
Breast Cancer
14%
Bone Metastasis
13%
Medronic Acid
13%
Prostate Cancer
13%
Sentinel-Node Mapping
11%
Gallium 68
11%
Melanoma
11%
Bone Disease
11%
Fluoride
11%
Hodgkin's Lymphoma
11%
Patient with Non-Hodgkins Lymphoma
11%
Diagnostic Accuracy
10%
Low Drug Dose
10%
Biopsy Technique
10%
Recurrent Disease
9%
Computer Assisted Tomography
9%
Hybrid Imaging
7%
Radioactive Tracer
7%
Squamous Cell Carcinoma
6%
Stereotypic Movement Disorder
6%
Primary Tumor
6%
Prostate Specific Membrane Antigen
6%
Carcinoembryonic Antigen
6%
Rectum Cancer
5%
Helix
5%
Abdominoperineal Resection
5%
Patient Assessment
5%
Skeleton Malformation
5%
Patient with Overweight
5%
Minimal Residual Disease
5%
Hepatocellular Carcinoma
5%
Keyphrases
Positron Emission Tomography/computed Tomography (PET/CT)
100%
Single-photon Emission Computed Tomography (SPECT)
30%
18F-FDG PET-CT
25%
Sentinel Lymph Node Mapping
23%
18F-fluorodeoxyglucose (18F-FDG)
22%
Parkinson's Disease
22%
Gamma Camera
20%
Standardized Uptake Value
19%
SPECT-CT
18%
Coincidence Imaging
18%
18F-DOPA PET
17%
Dual Head
17%
Lymphoscintigraphy
16%
Bone Scintigraphy
15%
Patients with Breast Cancer
14%
Positive Predictive Value
14%
Negative Predictive Value
13%
CT Findings
13%
Fluorodeoxyglucose
13%
99mTc-phytate
13%
FDG Uptake
12%
Lymphoma
12%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
12%
CT Pattern
11%
High-grade Prostate Cancer
11%
Hodgkin Disease
11%
Mutation Carriers
11%
Non-Hodgkin Lymphoma
11%
Extranodal Involvement
11%
Sentinel Lymph Node
11%
LRRK2 Gene
11%
Skeletal Disease
11%
18F-fluorocholine PET/CT
11%
CT System
11%
18F-fluoride PET
11%
Marijuana
11%
Regular Users
11%
Tetrahydrocannabinol
11%
Malignancy
11%
Planar Images
11%
Tumor
10%
Head-mounted Camera
10%
Diagnostic Accuracy
10%
Molecular Breast Imaging
9%
Consecutive Patients
9%
Low-dose CT
9%
Recurrent Colorectal Cancer
9%
CT Images
9%
CT Studies
9%
Patient Assessment
8%